| T4 polynucleotide kinase |
drug |
2 |
1 |
New England Biolabs T4 PNK |
| Tac1 |
gene |
2 |
2 |
|
| tachycardia |
phenotype |
3 |
3 |
|
| TACR3 |
gene |
3 |
2 |
tachykinin receptor 3 |
| TAG consortium |
cohort |
2 |
2 |
|
| tag SNPs |
cohort |
4 |
2 |
|
| tamoxifen |
drug |
5 |
1 |
|
| Taq1A allele |
variant |
2 |
2 |
DRD2 Taq1A |
| TaqMan assay |
drug |
8 |
5 |
Applied Biosystems, TaqMan assays, TaqMan®, TaqMan® assay, TaqMan® assays |
| TaqMan Universal PCR Master Mix |
drug |
5 |
1 |
TaqMan® Universal PCR Master Mix |
| tardive dyskinesia |
phenotype |
2 |
1 |
TD |
| target cohort |
cohort |
4 |
1 |
adults in our target cohort, target cohort |
| target gene |
gene |
4 |
1 |
target genes |
| target population |
cohort |
4 |
2 |
target subpopulation |
| target stimulus |
phenotype |
2 |
3 |
target |
| task |
phenotype |
2 |
2 |
TASK, pure strategy, task condition |
| task performance |
phenotype |
5 |
2 |
ability to perform certain tasks, task performance |
| task-related brain activity |
phenotype |
3 |
2 |
task related activity |
| tau |
phenotype |
4 |
— |
hyperphosphorylated Tau, tau protein |
| tauopathy |
phenotype |
3 |
1 |
|
